Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 4, 2009, Pages 728-729

  Delluc, Aurélien ^a,b   Mottier, D ^a,b   Le Gal, G ^a   Oger, E ^b   Lacut, K ^a,b  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BLOOD CLOTTING TIME; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; UNDERWEIGHT; VENOUS THROMBOEMBOLISM;

EID: 63049112447     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03280.x     Document Type: Letter

References (9)

1. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162: 1182-9.
2. Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain J-H, Roguedas A-M, Mottier D. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: Results from the EDITH study: A hospital-based case-control study. J Thromb Haemost 2006; 4: 793-9.
3. Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord 2001; 25: 212-8.
4. Hankey CR, Lean ME, Lowe GD, Rumley A, Woodward M. Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris. Eur J Clin Nutr 2002; 56: 1039-45.
5. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298: 2028-37.
6. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26: 1046-53.
7. Barba R, Zapatero A, Losa JE, Valdes V, Todoli JA, Di Micco P, Monreal M. Body mass index and mortality in patients with acute venous thromboembolism: Findings from the RIETE registry. J Thromb Haemost 2008; 6: 595-600.
8. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LAM, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJV, Solomon SD, for the CHARM Investigators. Body Mass Index and prognosis in patients with chronic heart failure: Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme. Circulation 2007; 116: 627-36.
9. Pocock SJ, McMurray JJV, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB, on behalf of the CHARM Investigators. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 2008; 29: 2641-50.